Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Endo

Endo International

Rank: 46

Dublin, Ireland
www.endo.com

2020 Revenues ($USD) : $2,903,074,000
2020 R&D spend : $158,902,000
2020 Number of Employees : 3,397
Fiscal Year End : 12/31/2020
Key People : Blaise Coleman, CEO

Endo International roots go back to a 1997 management buyout at DuPont Merck, where the generics division had gone by the name Endo Laboratories. A maker of painkillers, including Percocet, it eliminated its entire U.S. pain products sales force in December 2016 as it faced increased scrutiny amid the opioid epidemic, according to its annual report for 2020. Endo International's areas of focus in 2021 include the launch of QWO, FDA-approved for the treatment of moderate to severe cellulite in women's buttocks. The company in September 2020 inked a non-exclusive agreement to provide fill-finish manufacturing services for Novavax's COVID-19 vaccine candidate. –CN

Endo headquarters

Endo headquarters

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE